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Their joint input focused on clinical evidence of the failure 
of animal-based models to predict effectiveness and safety 
of chemical agents in drug research. Dr Eleanore Irvine 
(Biogelx Inc., Scotland, UK) introduced new 2D/3D culture 
methods using self-assembling hydrogels made from di- or 
tri-peptide components that can be used as coating for 2D 
cultures and for embedding cells in 3D models. The stiff-
ness of the gel can be regulated depending on a cell culture’s 
requirements by changing the ratio of powder to water and 
the hydrogels can be functionalized with proteins and growth 
factors. Dr Silvia Letasiova (MatTek In Vitro Life Science 
Laboratories, Bratislava, Slovakia) introduced an in vitro al-
ternative to the animal-based Draize Eye Irritation test. Epi-
Ocular™ is a 3D reconstruction of human cornea developed 
by culturing normal, human-derived epidermal keratinocytes 
to form a stratified, squamous epithelium, which can be used 
for ocular irritation assessment of cosmetic, personal care and 
household products. Dr Vladimir Mazurov (acCELLerate 
GmbH, Hamburg, Germany) presented the acCELLerate in 
The 3rd edition of the advanced theoretical-training course 
“Giving meaning to alternative methods to animal testing” 
was held in Genoa on July 6-7, 2017. This course, chaired by 
Prof. Anna Maria Bassi (LARF-DIMES, University of Genoa, 
Italy) with the valuable support of the LARF Research Team, 
provided an update on new in vitro approaches. The welcome 
addresses were given by Prof. Marco Frascio, Prof. Adriana 
Voci, as Coordinators of Medicine and Surgery, and Biologi-
cal Sciences degrees, respectively, of the University of Genoa, 
Italy, and by Dr Giuliano Grignaschi, head of the Animal Care 
Unit – Mario Negri Institute, Milano, Italy. In their welcome 
speech, all stressed the relevance of new in vitro technologies 
to improve the application of in vitro methods in toxicological 
research. The theoretical modules included talks by specialists 
from companies engaged in the field of advanced in vitro tech-
nologies, who offered participants the possibility to try out their 
technologies in the training modules. 
The ethical issues associated with animal-based research 
were the topic of contributions by Prof. Rosagemma Ciliberti, 
Ilaria Baldelli (DISSAL, University of Genoa, Italy) and 
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vitro services, which include cytotoxicity assay kits containing 
Frozen Instant Cells (THP-1, HepG2, Caco2, HaCaT, Jurkat, 
3T3, etc). The cells are cryopreserved at a highly functional 
state and are ready-to-use without prior cultivation, passag-
ing or counting. Cell handling, seeding protocols and incuba-
tion times are optimized to achieve a robust reproducibility 
and reliability of bioassays. Dr Costanza Rovida (CAAT- 
Europe) gave an overview from development of alternative 
methods to EURL-ECVAM validation processes and imple-
mentation of regulatory tests. Good Cell Culture Practice is 
a prerequisite to assure the quality and the traceability of all 
materials and methods used and to establish and maintain ad-
equate measures to protect individuals and the environment 
from potential hazards, to provide relevant and adequate 
education and training for all personnel, and thus to promote 
high quality work and safety. Dr Susanna Alloisio (ETT spa, 
Genoa, Italy), introduced the “High Throughput Electrophysi-
ology Assay” for functional neurotoxicity prediction. This 
method is based on the microelectrode array (MEA), a sensi-
tive and high information content system allowing long-term 
recordings that can be used to evaluate the neurotoxic poten-
tial of agrochemicals, chemicals, drugs, “smart” drugs and 
biotoxins. Dr Massimo Di Donato (Tebu-bio, Milan, Italy) 
offered an overview of the use of human primary cells and 
models for cosmetic and metabolic assays. He then focused 
on recombinant CYP preparations like bactosomes, bacterial 
membranes containing cytochrome P450s co-expressed with 
NADPH-CYP reductase, which have a higher specific activ-
ity than liver microsomes and can be used for the production 
of high quantities of metabolites as drug candidates. Dr Di 
Donato also spoke about synthetic matrixes for coating plates, 
specialized plates that enable cells to auto-regulate oxygen 
and CO2 levels in culture media, and a cellular invasion assay. 
Dr Paola Miranda (BioSPA, Milano, Italy) presented a 3-D 
hydrogel system (Cellends Hydrogel Technology, Germany) 
based on maleimide-functionalized polymer and a thiol-func-
tionalized crosslinker. These two components can be function-
alized for cell recovery with dextran or Cd-link to allow enzy-
matic matrix degradation. The gelling speed can be controlled 
by adjusting the pH or by modifying maleimide-functionalized 
polymer/thiol-functionalized crosslinker concentration. Dr 
Tommaso Sbrana and Dr Daniele Cei (IVTech, Massarosa, 
Lucca, Italy) introduced the 3D dynamic millifluidic models 
Live box 1 (single flow bioreactor) and Live box 2 (double 
flow bioreactor). The bioreactors ensure a balanced, continu-
ous medium flow to cultured cells via a peristaltic pump. Prof. 
Anna Maria Bassi (LARF-DIMES, University of Genoa, 
Italy), explained the importance of predictive toxicology to 
protect human health. The use of animal models only is un-
able to achieve this goal, because animal models often do not 
mimic human diseases sufficiently (e.g., Alzheimer or autism 
models). Therefore, the number of laboratories involved in the 
research and development of non-animal methods is growing. 
She referred to promising approaches such as stem cells and 
induced pluripotent stem cells (iPSCs), which can be differen-
tiated into several human cell types, and new bioinformatics 
and mathematical tools, which can be integrated into multidis-
ciplinary approaches. 
In the training modules the experts offered several hands-on 
experiences of the presented technologies to each participant 
with the assistance of the LARF team (Chiara Scanarotti, Ste-
fania Vernazza and Sara Tirendi). The evaluation questionnaires 
revealed satisfaction of all participants, who requested the 
scheduling of other advanced courses. This positive feedback 
highlights how the promotion and organization of training ac-
tivities can promote the interest in and future use of non-animal 
models.
We thank Dr Helena Kandarova, Dr Silvia Letasiova, 
Dr Tommaso Sbrana, Dr Daniele Cei, Dr Paola Miranda, 
Dr Eleanore Irvine and Dr Valery Shevchenko for their invalu-
able contribution to the success of the course.
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